Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy

Journal of Clinical and Experimental Hepatology - Tập 6 - Trang 246-249 - 2016
Sern Wei Yeoh1
1Department of Gastroenterology and Hepatology, Eastern Health, Level 2, 5 Arnold Street, Box Hill, Victoria 3128, Australia

Tài liệu tham khảo

Newell-Price, 2006, Cushing's syndrome, Lancet, 367, 1605, 10.1016/S0140-6736(06)68699-6 Blondin, 2013, Iatrogenic Cushing syndrome in patients receiving inhaled budesonide and itraconazole or ritonavir: two cases and literature review, Endocr Pract, 19, e138, 10.4158/EP13122.CR Kedem, 2010, Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient, J Asthma, 47, 830, 10.3109/02770903.2010.485666 Gray, 2010, Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide, S Afr Med J, 100, 296, 10.7196/SAMJ.3848 Spruyt, 2012, Inhaled corticosteroids in persons with HIV infection: not that harmless, Acta Clin Belg, 67, 120 le Roux, 2001, Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy, HIV Med, 2, 133, 10.1046/j.1468-1293.2001.00058.x Yoganathan, 2012, Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection, Int J STD AIDS, 23, 520, 10.1258/ijsa.2011.011408 Frankel, 2011, Cushing's syndrome due to antiretroviral–budesonide interaction, Ann Pharmacother, 45, 823, 10.1345/aph.1P731 Edsbäcker, 2004, Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease, Clin Pharmacokinet, 43, 803 Sagir, 2003, Inhibition of cytochrome P4503A: relevant drug interactions in gastroenterology, Digestion, 68, 41, 10.1159/000073224 Zeuzem, 2014, Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin, N Engl J Med, 370, 1604, 10.1056/NEJMoa1401561 Poordad, 2014, ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis, N Engl J Med, 370, 1973, 10.1056/NEJMoa1402869 McCall, 2016, Australia commits funds to curb hepatitis C epidemic, Lancet, 387, 419, 10.1016/S0140-6736(16)00212-9 Burgess, 2015, Drug interactions with direct-acting antivirals for hepatitis C: implications for HIV and transplant patients, Ann Pharmacother, 49, 674, 10.1177/1060028015576180 Pockros, 2016, Efficacy of direct-acting antiviral combination for patients with hepatitis C virus genotype 1 infection and severe renal impairment or end-stage renal disease, Gastroenterology, 10.1053/j.gastro.2016.02.078